Analyst Ratings for Monte Rosa Therapeutics (GLUE)
GLUE Rating Summary
GLUE Price Target Summary
- Highest: $40.00 (Jefferies)
- Lowest: $19.00 (UBS)
- Average: $29.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.50 (+202.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
Avg. $ Target:
$29.50 (+202.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/1/2026 | H.C. Wainwright » Updated 10/5/2026 |
Mitchell S. Kapoor | New Coverage | Buy (N/A) |
25.00 (N/A) |
11.93 (9.74) |
-18.36% | Details |
| 8/22/2026 | TD Cowen | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
14.78 (9.74) |
-34.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
